Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2018, Article ID 6872748, 5 pages
Case Report

Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock

1Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USA
2Department of Cardiovascular Surgery, Beaumont Health System, Royal Oak, MI, USA

Correspondence should be addressed to Ivan D. Hanson; gro.tnomuaeb@nosnah.navi

Received 30 November 2017; Accepted 29 January 2018; Published 13 March 2018

Academic Editor: Markus Ferrari

Copyright © 2018 Ivan D. Hanson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.